Circulating kidney injury molecule‐1 as a biomarker of renal parameters in diabetic kidney disease
نویسندگان
چکیده
منابع مشابه
Non-albuminuric Diabetic Kidney Disease in Diabetic Patients: A Review
Introduction: The constantly increasing incidence of type 2 diabetes, probably due to obesity and sedentary life, has led to the increased incidence of macro- and microvascular diabetic complications such as nephropathy. Despite the prompt efforts to develop effective treatments for diabetes and slow the progression of its complications, it is still reported as the most common cause of chronic ...
متن کاملCirculating CXCL16 in Diabetic Kidney Disease.
BACKGROUND/AIMS Chronic kidney disease and, specifically, diabetic kidney disease, is among the fastest increasing causes of death worldwide. A better understanding of the factors contributing to the high mortality may help design novel monitoring and therapeutic approaches. CXCL16 is both a cholesterol receptor and a chemokine with a potential role in vascular injury and inflammation. We aimed...
متن کاملHyaluronic Acid as a New Biomarker to Differentiate Acute Kidney Injury From Chronic Kidney Disease.
INTRODUCTION It may be difficult to differentiate acute kidney injury from chronic kidney disease in patients with no past medical reports of kidney function. This study aimed to investigate the role of serum hyaluronic acid (HA), which is known as a marker of fibrosis, in differential diagnosis of kidney failure. MATERIALS AND METHODS A total of 90 patients (52 women and 38 mne) admitted to ...
متن کاملCirculating miRNAs as biomarkers of kidney disease
Interest in microRNAs (miRNAs) has dramatically increased in recent years not only because they regulate mRNA expression, and thus many physiological or pathophysiological processes, but also because they could serve as biomarkers. Next to analysis of tissue miRNA expression, measurement in body fluids such as blood or urine is attractive because miRNA in microvesicles or bound to protein is ve...
متن کاملUrine albumin as a biomarker in acute kidney injury.
ACUTE KIDNEY INJURY (AKI) is a common clinical condition that is associated with significantly high rates of morbidity and mortality particularly in critically ill patients (1, 2, 10, 18). Despite fundamental advances in understanding the etiology and pathophysiology of AKI the current therapeutic approaches remain limited to supportive measures (e.g., dialysis). Treatment for AKI is confounded...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Diabetes Investigation
سال: 2019
ISSN: 2040-1116,2040-1124
DOI: 10.1111/jdi.13139